amp;#-12,)…; Physitrack Quarterly Developments; Wellness Quarterly Developments; Product-led Growth: Innovation in Action." /> amp;#-12,)…; Physitrack Quarterly Developments; Wellness Quarterly Developments; Product-led Growth: Innovation in Action." /> amp;#-12,)…; Physitrack Quarterly Developments; Wellness Quarterly Developments; Product-led Growth: Innovation in Action." />

Physitrack Limited · OMXSTO:PTRK

Physitrack — Q3 2024 Earnings Presentation

22 slides from Physitrack's earnings presentation, Nov 12, 2024

Slide 1: _˓ɤΤǸʹʧ˷ʊ‫ڑ‬ ʹʔɤ‫ڑ‬ǈ̇ͅ˓ɒժͣ‫ڑ‬ ǈɤ˓˓ȿɤʧ˷ʊ
_˓ɤΤǸʹʧ˷ʊ‫ڑ‬ ʹʔɤ‫ڑ‬ǈ̇ͅ˓ɒժͣ‫ڑ‬ ǈɤ˓˓ȿɤʧ˷ʊ
Slide 2: Forward-looking Statement
̇ͅΨǸͅɒՑ˓̇̇ˋʧ˷ʊ‫ڑ‬ƋʹǸʹɤ˰ɤ˷ʹ ƙʔʧͣ‫̻ͅڑ‬ɤͣɤ˷ʹǸʹʧ̇˷‫ڑ‬Ɇ̇˷ʹǸʧ˷ͣ‫ڑ‬ɆɤͅʹǸʧ˷‫ڑ‬ʅ̇ͅΨǸͅɒՑ˓̇̇ˋʧ˷ʊ‫ʹͣڑ‬Ǹʹɤ˰ɤ˷ʹͣ‫ڑ‬Ǹ˷ɒ‫̻̇ڑ‬ʧ˷Ց ǸɆʹ΃Ǹ˓‫ͅڑ‬ɤͣ΃˓ʹͣջ‫ڑ‬ʧ˷Ɇ˓΃ɒʧ˷ʊ‫ʹڑ‬ʔɤ‫ڑ‬İ˰̻Ǹ˷ζլͣ‫ڑ‬ɆǸͣʔ‫ڑ‬ʅ˓̇Ψջ‫ڑ‬ʅʧ˷Ǹ˷ɆʧǸ˓‫ڑ‬Ɇ̇˷ɒʧʹʧ̇˷‫ڑ‬Ǹ˷ɒ‫ڑ‬ ʧ̇˷ͣռ‫̇ͅ ڑ‬ΨǸͅɒՑ˓̇̇ˋʧ˷ʊ‫ʹͣ ڑ‬Ǹʹɤ˰ɤ˷ʹͣ‫ ڑ‬Ǹͅɤ‫ʹͣ ڑ‬Ǹʹɤ˰ɤ˷ʹͣ‫ʹ ڑ‬ʔǸʹ‫ ڑ‬ɒ̇‫ͅ ڑʹ̇˷ ڑ‬ɤ˓Ǹʹɤ‫ڑ
Slide 3: Agenda
ʊɤ˷ɒǸ ŽԒ‫ڑ‬ʧ˷‫ڑ‬Ƌʔ̇ͅʹ‫ڑ‬ A΃ͣʧ˷ɤͣͣ‫ڑ‬ƥ̻ɒǸʹɤͣ ʧ˷Ǹ˷ɆʧǸ˓‫ڑ‬žɤͣ΃˓ʹͣ ƋʹͅǸʹɤʊζ‫ڑ‬Ǹ˷ɒ‫ڑ‬ŀ΃ʹ˓̇̇ˋ Ž԰ ¡ɤ˷ͅʧˋ‫ڑ‬ģ̇˓ʧ˷ IʔǸͅ˓̇ʹʹɤ‫̇̇ڑ‬ɒΨʧ˷ I_ŀ‫ڑ‬԰‫ڑ‬Ɇ̇Ցʅ̇΃˷ɒɤͅ Iŀ
Slide 4: Q3 in Short
ŽԒ‫ڑ‬ʧ˷‫ڑ‬Ƌʔ̇ͅʹ
Slide 5: Quarterly Subscription Revenue
ƙʔɤ‫ˋڑ̻΃̇ͅڑ‬ɤɤ̻ͣ‫˷ڑ‬ǸΤʧʊǸʹʧ˷ʊ‫ʹڑ‬ʔɤ‫ڑ‬Ɇ̇˷ʹͅǸͣʹʧ˷ʊ‫ڑ‬ĘʧʅɤɆǸͅɤ‫ڑ‬Ǹ˷ɒ‫ڑ‬ǈɤ˓˓˷ɤͣͣ‫̻ڑ‬ɤͅʅ̇ͅ˰Ǹ˷Ɇɤ‫ڑ‬Ψʔʧ˓ɤ‫ڑ‬Ɇ̇˷ʹʧ˷΃ʧ˷ʊ‫̻ͣ̇ڑʹ̻ͣ̇ڑ̇ʹڑ‬ʧʹʧΤɤ‫˷ڑ‬ɤʹ‫ڑ‬ʊ̇ͅΨʹʔռ‫ڑ‬ ԏٜ ԏԙٜ ӵԎռԓ˰ Ԑԓٜ Ž΃Ǹͅʹɤͅ˓ζ Ƌ΃ȿͣɆͅʧ̻ʹʧ̇˷ ŽԒ‫ڑ‬ԐԎԐԓ‫ڑ‬ɆǸͣʔ‫ڑ‬ʅ˓̇Ψ ɒ˃΃ͣʹɤɒ‫_ڑ‬AÅƙT‫ڑ‬ǕƙT ͅɤΤɤ˷΃ɤ‫ڑ‬ʊ̇ͅΨʹʔ ͅɤΤɤ˷΃ɤ‫ڑ‬ʊ̇ͅΨ˷ ˷ɤʊǸʹʧΤɤ ʧ˷ɆͅɤǸͣɤɒ‫̇ʹڑ‬ I΃ͅͅɤ
Slide 6: Business Updates
A΃ͣʧ˷ɤͣͣ‫ڑ‬ƥ̻ɒǸʹɤͣ
Slide 7: ."$)%/+)0"-12&--)'12&-)3#4&)"-)/&''56+-1%1+2&7)%+)8#61%#'19&)+2)128

amp;#-12,) 71,1%#')3&#'%38#amp;)7&:#27)#27)8+$6+$#%&)/…

."$)%/+)0"-12&--)'12&-)3#4&)"-)/&''56+-1%1+2&7)%+)8#61%#'19&)+2)128amp;#-12,) 71,1%#')3&#'%38#amp;)7&:#27)#27)8+$6+$#%&)/&''0&12,)83#''&2,&-; !"# D#110#++ V+#$)5,-1'&=?$,55$,&#,4$ '1$#=)5'E##$6#55D#/+* !#-"0'1'32$,'& #5)1'2#&+ C/,#-*&# H#,=5#44$,+.$#11/3/#+- 3,&#$4'5(-/'+4 !#-"0'1'32$,'& "#*16"-*&#$)&'4

Slide 8: Physitrack Quarterly Developments

ĘʧʅɤɆǸͅɤ‫ڑ‬Ž΃Ǹͅʹɤͅ˓ζ‫ڑ‬TɤΤɤ˓̻̇˰ɤ˷ʹͣ ŽԒ‫¡ڑ‬ʧʊʔ˓ʧʊʔʹͣ ԏԗٜ‫ڑ‬ʊ̇ͅΨʹʔ‫ڑ‬ʧ˷‫˓ڑ‬ʧɆɤ˷ͣɤ‫˰΃˷ڑ‬ȿɤͣͅ‫ڑ‬Ψʧʹʔʧ˷‫ڑ‬ĘʧʅɤɆǸͅɤ ŀ΃ͅ‫ ڑ‬Ŷ̇ͅɒ΃ɆʹՑ˓ɤɒ‫ ڑ‬ʊ̇ͅΨʹʔ‫ͅ ڑ‬ɤΤɤ˷΃ɤ‫ ڑ‬ʊɤ˷ɤͅǸʹʧ̇˷‫ͣ ڑ‬ʧʹͣ‫ ڑ‬Ǹʹ‫ ڑ‬ʔʧͣʹ̇ͅʧɆ‫ ڑ‬ʔʧʊʔͣ‫ ڑ‬Ψʧʹʔ‫ ڑ‬Ǹ΃ʹ̇˰Ǹʹɤɒ‫ڑ‬ ͣǸ˓ɤͣ‫ ڑ‬ʅ΃˷˷ɤ˓ͣ‫ˋ ڑ‬ɤɤ̻‫ ڑ‬ȿɤʧ˷ʊ‫ʹ̻̇ ڑ‬ʧ˰ʧͣɤɒռ‫ ڑ‬ƙʔɤ‫ ڑ‬ʧ˷Τɤͣʹ˰ɤ˷ʹͣ‫ ڑ‬ʧ˷ʹ̇

Slide 9: Wellness Quarterly Developments

ǈɤ˓˓˷ɤͣͣ‫ڑ‬Ž΃Ǹͅʹɤͅ˓ζ‫ڑ‬TɤΤɤ˓̻̇˰ɤ˷ʹͣ ŽԒ‫¡ڑ‬ʧʊʔ˓ʧʊʔʹͣ ǕƙT‫ͅڑ‬ɤΤɤ˷΃ɤջ ‫ڑ‬ǈɤ˓˓˷ɤͣͣ‫ͣڑ‬ɤʊ˰ɤ˷ʹ ǈʔʧ˓ɤ‫˷ ڑ‬ɤΨ‫ͣ ڑ‬Ǹ˓ɤͣ‫̇ ڑ‬ʅ‫ ڑ‬IʔǸ˰̻ʧ̇˷‫¡ ڑ‬ɤǸ˓ʹʔ‫˓ ڑ‬ʧɆɤ˷ͣɤͣ‫ ڑ‬ʧ˷‫ʹ ڑ‬ʔɤ‫ ڑ‬ƥĎ‫ ڑ‬ʔǸΤɤ‫ ڑ‬ȿɤɤ˷‫̇˓ ڑ‬Ψɤͅ‫ʹ ڑ‬ʔǸ˷‫ڑ‬ 2.9 ɤα̻ɤɆʹɤɒջ‫ʹڑ‬ʔɤ‫ڑ‬ī̇ͅɒʧɆ‫ͣڑ‬Ǹ˓ɤͣ‫̻ڑ‬ʧ̻ɤ˓ʧ˷ɤ‫ڑ‬ʧͣ‫ڑ‬ȿ΃ʧ˓ɒʧ˷ʊ‫˷ڑ̻΃ڑ‬ʧɆɤ˓ζ‫ڑ‬Ψʧʹʔ‫ڑ‬ʧ˷ʧʹʧǸ˓‫ڑ

Slide 10: Product-led Growth: Innovation in Action

Ŷ̇ͅɒ΃ɆʹՑĘɤɒ‫̇ͅڑ‬Ψʹʔ Å˷˷̇ΤǸʹʧ̇˷‫ڑ‬ʧ˷‫ڑ‬Ɇʹʧ̇˷ Å˷‫ڑ‬ԐԎԐԓ ջ‫ڑ‬Ψɤ‫ڑ‬ʔǸΤɤ‫ͣڑ‬ɤɤ˷‫ʹڑ‬ʔɤ‫˷̇ͅʹͣڑ‬ʊɤͣʹ‫ڑ‬ ɒɤΤɤ˓̻̇˰ɤ˷ʹ‫̇ڑ‬ʅ‫ڑ‬Ŷ̇ͅɒ΃ɆʹՑ˓ɤɒ‫ڑ‬ʊ̇ͅΨʹʔ‫ͣڑ‬ʧ˷Ɇɤ ̇΃ͅ‫ڑ‬ʔʧͣʹ̇ͅʧɆǸ˓‫ڑ‬ʔʧʊʔͣ‫̇ڑ‬ʅ‫ڑ‬ԐԎԐԎտ ‫ڑ‬ ƥ̻ɒǸʹɤɒ‫˰ڑ‬ɤͣͣǸʊʧ˷ʊ‫ڑ‬Ǹ˷ɒ‫ڑ‬ȿͅǸ˷ɒʧ˷ʊջ‫ڑ‬ɆǸʹɤͅʧ˷ʊ‫ڑ̇ʹڑ‬ Ǹ‫̇ͅ˰ڑ‬ɤ‫̻̇ͣڑ‬ʔʧͣʹʧɆǸʹɤɒ‫ڑ‬Ǹ΃ɒʧɤ˷Ɇɤ ռ‫ڑ‬ Ƌʧʊ˷Ց΃̻‫ ڑ‬ʅ΃˷˷ɤ˓

Slide 11: Financial Results

ʧ˷Ǹ˷ɆʧǸ˓‫ڑ‬žɤͣ΃˓ʹͣ

Slide 12: Q3 Financial Highlights

ŽԒ‫ڑ‬ʧ˷Ǹ˷ɆʧǸ˓‫¡ڑ‬ʧʊʔ˓ʧʊʔʹͣ ԙ‫ʹ˷̇˰ڑ‬ʔͣ‫ͅڑ‬ɤΤɤ˷΃ɤ ԙ‫ʹ˷̇˰ڑ‬ʔͣ‫_ڑ‬AÅƙT ӵԏԐռԎ˰‫ ڑ‬ԻŽԒ‫ڑ‬ԐԎԐԒտ‫ ڑ‬ӵԏԏռԒ˰Լ Ԕٜ ӵԐռԔ˰‫ڑ‬ԻŽԒ‫ڑ‬ԐԎԐԒտ‫ ڑ‬ӵԐռԒ˰Լ ԏԎٜ ԙ‫ʹ˷̇˰ڑ‬ʔͣ‫΃ͣڑ‬ȿͣɆͅʧ̻ʹʧ̇˷‫ͅڑ‬ɤΤɤ˷΃ɤ ԙ‫ʹ˷̇˰ڑ‬ʔͣ‫ڑ‬IǸͣʔʅ˓̇Ψ ӵԙռԘ˰ՍԘԐٜ ԏԙٜ ӵԏռԙ˰‫ڑ‬ԻŽԒ‫ڑ‬ԐԎԐԒտ‫ڑڑ‬ӵԏռԓ˰Լ ԐԘٜ ԻŽԒ‫ڑ‬ԐԎԐԒտ‫ ڑ‬ӵԘռԐ˰ՍԗԐٜԼ ԙ‫ʹ˷̇˰ڑ‬ʔͣ‫ڑ‬Ǹɒ˃΃ͣʹɤɒ‫_ڑ‬AÅƙT

Slide 13: Maintaining Revenue Growth

ģǸʧ˷ʹǸʧ˷ʧ˷ʊ‫ڑ‬žɤΤɤ˷΃ɤ‫̇ͅڑ‬Ψʹʔ Footnotes: 2022 pro-forma figures represenƩ he results of Wellnow, PT Courses and Champion Health had they been acquired by the business on 1 January 2022. OrganŝĐĮŐƵres represent the current year results translated into Euro at the prevailing average exchange rates in

Slide 14: Significant Growth in Subscription Revenue

Ƌʧʊ˷ʧʅʧɆǸ˷ʹ‫̇ͅڑ‬Ψʹʔ‫ڑ‬Å˷‫ڑ‬Ƌ΃ȿͣɆͅʧ̻ʹʧ̇˷‫ڑ‬žɤΤɤ˷΃ɤ

Slide 15: Adjusted EBITDA

ɒ˃΃ͣʹɤɒ‫_ڑ‬AÅƙT 47% 2% 47% 6%

Slide 16: Cash Flow

IǸͣʔʅ˓̇Ψ Available liquidity €1.3m ӵԏռԒ˰

Slide 17: Cash Flow: Impacted by Seasonal Impacts of Working Capital

IǸͣʔՑʅ˓̇Ψ‫ڑ‬Å˰̻ǸɆʹɤɒ‫ڑ‬ȿζ‫ڑ‬ƋɤǸͣ̇˷Ǹ˓‫ڑ‬Å˰̻ǸɆʹͣ‫̇ڑ‬ʅ‫ڑ‬ǈ̇ͅˋʧ˷ʊ‫ڑ‬IǸ̻ʧʹǸ˓ ԻԏԼ ͅɤɤ‫ڑ‬ɆǸͣʔ‫ڑ‬ʅ˓̇Ψ‫ڑ‬ʧͣ‫ڑ‬ɒɤʅʧ˷ɤɒ‫ڑ‬Ǹͣ‫˷ڑ‬ɤʹ‫ڑ‬ɆǸͣʔ‫ڑ‬ʅ̇ͅ˰‫̻̇ڑ‬ɤͅǸʹʧ˷ʊ‫ڑ‬ǸɆʹʧΤʧʹʧɤͣջ‫˓ڑ‬ɤͣͣ‫ͅ΃̻ڑ‬ɆʔǸͣɤ‫̇ڑ‬ʅ‫ڑ‬ʧ˷ʹǸ˷ʊʧȿ˓ɤ‫ڑ‬Ǹͣͣɤʹͣ‫ڑ‬Ǹ˷ɒ‫̻̻̇ͅڑ‬ɤͅʹζջ‫˓̻ڑ‬Ǹ˷ʹ‫ڑ‬Ǹ˷ɒ‫ڑ‬ɤ́΃ʧ̻˰ɤ˷ʹ‫ڑ‬Ǹ˷ɒ‫ڑ‬ʅʧ˷Ǹ˷Ɇɤ‫ڑ‬Ɇ̇ͣʹͣռ _α̻ɤɆʹǸʹʧ̇˷‫ʹڑ‬ʔɤ‫ڑ̻΃̇ͅڑ

Slide 18: Balance Sheet

AǸ˓Ǹ˷Ɇɤ‫ڑ‬Ƌʔɤɤʹ ԒԎ‫ڑ‬Ƌɤ̻ʹɤ˰ȿɤͅ‫ڑ‬ԐԎԐԓ ԒԎ‫ڑ‬Ƌɤ̻ʹɤ˰ȿɤͅ‫ڑ‬ԐԎԐԒ _΃̇ͣͅ‫ڑ‬ժԎԎԎ ̇̇ɒΨʧ˓˓ջ‫ڑ‬ʧ˷ʹǸ˷ʊʧȿ˓ɤͣ‫ڑ‬Ǹ˷ɒ‫ڑ‬Ŷ_ ԒԓջԐԖԓ‫ڑ‬ ԒԔջԘԏԓ‫ڑ‬ IǸͣʔ‫ڑ‬Ǹ˷ɒ‫ڑ‬ɆǸͣʔ‫ڑ‬ɤ́΃ʧΤǸ˓ɤ˷ʹͣ ԔԐԐ ԓԓԎ Ȧ̇ͅͅΨʧ˷ʊͣ ԻԓջԘԔԐԼ‫ڑ‬ ԻԒջԗԘԗԼ‫ڑ‬ ƙͅǸɒɤ‫ڑ‬Ǹ˷ɒ‫ʹ̇ڑ‬ʔɤͅ‫ͅڑ‬ɤɆɤʧΤǸȿ˓ɤͣ Ԓջԙԓԓ‫ڑ‬ ԓջԓԐԘ‫ڑ‬ ƙͅǸɒɤ‫ڑ‬Ǹ˷ɒ‫ʹ̇ڑ‬ʔɤͅ‫̻ڑ‬ǸζǸȿ˓ɤͣ ԻԐջԎԘԖԼ ԻԐջԔԘԎԼ

Slide 19: Strategy and Outlook

ƋʹͅǸʹɤʊζ‫ڑ‬Ǹ˷ɒ‫ڑ‬ŀ΃ʹ˓̇̇ˋ

Slide 20: Our Unique Value Proposition

ŀ΃ͅ‫˷΃ڑ‬ʧ́΃ɤ‫ڑ‬ΤǸ˓΃ɤ‫̻̻ͣ̇̇ͅڑ‬ʧʹʧ̇˷ ¡̇˓ʧͣʹʧɆ‫̇ڑ‬ʅʅɤͅʧ˷ʊջ‫̻̇ ڑ‬Ψɤͅɤɒ‫ڑ‬ȿζ‫̻̇ʹڑ‬Ց̇ʅՑʹʔɤՑ˓ʧ˷ɤ‫ʹڑ‬ɤɆʔ ƙͅ΃ɤ‫̻̇ͅڑ‬ɒ΃Ɇʹ‫˰ڑ‬Ǹͅˋɤʹ‫ڑ‬ʅʧʹ ŶͅʧɆɤͣ‫ڑ‬ʧ˷‫ͅڑ‬ɤ˓Ǹʹʧ̇˷‫ʹڑ̇ʹڑ‬ʔɤ‫˰ڑ‬Ǹͅˋɤʹ‫ͅڑ‬Ǹʹʔɤͅ‫ʹڑ‬ʔǸ˷‫ڑ‬ʊ̇ͅΨʹʔ‫ڑ‬ɤα̻ɤɆʹǸʹʧ̇˷ͣ IǸʹɤͅʧ˷ʊ‫ڑ̇ʹڑ‬Ɇ̇˷ͣ΃˰ɤͅ‫ͅʹڑ‬ɤ˷ɒͣ Å˰̻̇ͅΤɤɒ‫̻ڑ‬Ǹʹʧɤ˷ʹ‫ʹ΃̇ڑ‬Ɇ̇˰ɤͣ‫ʹڑ‬ʔ̇ͅ΃ʊʔ‫̇ͅ˰ڑ‬ɤ‫̻ڑ‬ɤͣ̇ͅ˷Ǹ˓ʧύɤ

Slide 21: How It All Comes Together

¡̇Ψ‫ڑ‬ʧʹ‫ڑ‬Ǹ˓˓‫ڑ‬Ɇ̇˰ɤͣ‫̇ʹڑ‬ʊɤʹʔɤͅ‫ڑ‬Ց‫ڑ‬ʧ˷Τɤͣʹʧ˷ʊ‫ڑ‬ʧ˷‫ڑ‬ŶʔζͣʧʹͅǸɆˋ ģǸͅˋɤʹ‫ڑˋ̇̇˓ʹ΃̇ڑ‬Ǹ˷ɒ‫̻ͣ̇ڑ‬ʧʹʧ̇˷ ̇Ɇ΃ͣ‫ͅڑ‬ɤǸͣ ¡ʧʊʔՑͅɤǸɆʔʧ˷ʊ‫ڑ‬ʅʧ˷Ǹ˷ɆʧǸ˓‫ڑ‬ʊ̇Ǹ˓ͣ ƙ̻̇Ց˓ʧ˷ɤ‫ڑ‬ʊ̇ͅΨʹʔ ŶʔζͣʧʹͅǸɆˋ‫ ڑ‬Ǹʧ˰ͣ‫ ڑ̇ʹ ڑ‬ǸɆʔʧɤΤɤ‫ ڑ‬Ǹ‫ ڑ‬ɒ̇΃ȿ˓ʧ˷ʊ‫̇ ڑ‬ʅ‫ڑ‬ ̇ͅΨʧ˷ʊ‫˰ڑ‬Ǹͅˋɤʹ‫ʹ̻̻̇ͅ΃ͣڑ‬ɤɒ‫ڑ‬ȿζ‫ڑ‬ ԏռ ģǸͅˋɤʹ‫ڑ‬ʊ̇ͅΨʹʔ‫ڑ‬ɒζ˷Ǹ˰ʧɆͣ ͅɤΤɤ˷΃ɤ‫

Slide 22: Ž԰

Ž԰

Physitrack — Q3 2024 Earnings Presentation on 6ix

6ix — News, calls and decks from 54,000 public companies

News releases, calls, decks and charts for 54,000 public companies in one place, with 6ix AI and an email when your companies put out news. Free for investors.

Please enable JavaScript to use all features of 6ix.com.